Related Experiment Video

Updated: Jul 28, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

182

[Molecular targeted therapy for acute myeloid leukemia]

Yuichi Ishikawa1

  • 1Department of Hematology and Oncology, Nagoya University Graduate School of Medicine.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|June 4, 2023
PubMed
Summary

Novel therapies are improving outcomes for acute myeloid leukemia (AML). Recent advancements include targeted agents and immunotherapies, offering new hope for patients with this complex blood cancer.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology
Keywords:
AMLGene mutationImmunotherapyMolecular targeted therapy

More Related Videos

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.3K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K

Related Experiment Videos

Last Updated: Jul 28, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

182
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.3K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K

Articles linked to this work by shared authors, journal, and citation graph.

Smartphone App-Based Eating Behavior Monitoring and Feedback Intervention for Glucocorticoid-Induced Appetite Increase in Patients With Systemic Lupus Erythematosus: Protocol for a Pilot Randomized Controlled Trial.

JMIR research protocols·2025

Unplanned Hospitalization Due to All-Cause Morbidity and Its Real-World Management Practices in Patients With Fontan Circulation.

Journal of the American Heart Association·2025

Left Lower Lobectomy for Lung Cancer Complicated by Unilateral Absence of the Left Pulmonary Artery: A Case Report.

Surgical case reports·2025

Association between sedentary behavior and sleep quality among urban white-collar workers with or at risk of metabolic syndrome: a secondary analysis of a randomized 3-month workplace lifestyle intervention trial.

Journal of occupational health·2025

An 11-year single-center experience of Norwood procedures in the neonates with hypoplastic left heart syndrome and variants.

Annals of pediatric cardiology·2025

Dasatinib is superior to imatinib in adult Ph + ALL: a propensity score-matched analysis of pooled JALSG trial data.

International journal of hematology·2025

[Clinical management of familial platelet disorder with associated myeloid malignancies: at the crossroads of hematology and clinical genetics].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[DDX41-mutated myeloid neoplasms].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Clinical significance of germline pathogenic variants associated with hematologic malignancies].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Future directions in clinical development of first-line therapy for diffuse large B-cell lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Novel therapeutic strategies to separate GVHD from GVL based on GVHD pathophysiology and mechanisms of leukemia relapse].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[New developments in cord blood transplantation: immunological characteristics and strategies for relapse prevention].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

PET RANO 1.0 vs. RANO 2.0 criteria for trial eligibility in IDH-wildtype glioblastoma: a retrospective, comparative study.

Neuro-oncology·2026

Precision Medicine in patients with rare forms of genetic obesity: Necessity for coordinated and structured care.

The Journal of clinical endocrinology and metabolism·2026

Advances in Formulation and Technological Strategies for Montelukast Pulmonary Delivery.

ACS omega·2026

Feasibility of Polylactic Acid-Polycaprolactone-Blended Microspheres in Transarterial Embolization Therapy.

ACS omega·2026

Exosomes in brain diseases: Mechanisms, advances, and perspectives.

Bioactive materials·2026

Quantification of Ocular Gene Therapy-Related Inflammation Using the VRMACS Grading System.

Ophthalmology science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us